Headache, Headache Medication, Headache News, Headache Treatments, HeadWise Podcast, Medication, Medications, Migraine, News to Know
Atogepant (QULIPTA) was just approved by the FDA as a daily oral preventive treatment for migraine. On this episode of Heads UP, Dr. Lindsay Weitzel asks migraine clinical trial expert Dr. Tim Smith all the hard questions: Can we take gepants like Nurtec or Ubrelvy for our acute migraine attacks if we are taking atogepant? How effective is atogepant and what are the side effects? Does it work as well as the injected monoclonal antibodies for migraine prevention?
--- Find More Articles ---
Access to Care Advocacy Alternative Therapy Annual Benefit Apps AQH AQH Review Ask the Expert Ask the Pharmacist Case Study Children College Migraine Corporate Leadership Council COVID Devices Diet Donation Ellen Aubry Award Employment Exercise Film and Television Award Frequently Asked Questions Fundraiser Gala Gift Guide Headache Headache Categories Headache Diary Headache Diet Headache Education Headache Fact Sheets Headache Fact Sheets- Spanish Headache Heroes Headache Medication Headache News Headache Research Headache Support Headache Tests Headache Tools Headache Treatments Headache Triggers Headache Webinar HeadFirst Digital Monthly Newsletter HeadWise Podcast In the Media Insurance Kid's Korner Lectureship Medication Medications Menstrual Migraine mental health MIDAS Questionnaire Migraine Migraine and Headache Awareness Month Migraine Art Migraine University Migraine University military Mindfulness My Headache Story National Headache Foundation News to Know NHF Board NHF Guest NHF News NHF Staff Operation Brainstorm Patient Assistance Programs Pick 3 Podcast Poetry Post Press Release Primary Care Migraine Productive Visits PTSD Reader's Mail Resources Resources for War Veterans Seeing a Doctor Seven Second Freeze Challenge Special Events Stories Study Triggers Uncategorized Veterans Video Work